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Abstract: Metal-driven self-assembly afforded a multitude of
fascinating supramolecular coordination complexes (SCCs)
with applications as catalysts, host–guest, and stimuli-respon-
sive systems. However, the interest in the biological applica-
tions of SCCs is only starting to emerge and thorough
characterization of their behavior in biological milieus is still
lacking. Herein, we report on the synthesis and detailed in-cell
tracking of a Pt2L2 metallacycle. We show that our hexagonal
supramolecule accumulates in cancer cell nuclei, exerting
a distinctive blue fluorescence staining of chromatin resistant to
UV photobleaching selectively in nucleolar G4-rich regions.
SCC co-localizes with epitopes of the quadruplex-specific
antibody BG4 and replaces other well-known G4 stabilizers.
Moreover, the photophysical changes accompanying the metal-
lacycle binding to G4s in solution (fluorescence quenching,
absorption enhancement) also take place intracellularly, allow-
ing its subcellular interaction tracking.
The thoughtful choice of transition metals and multidentate
ligands allows for the generation of a number of self-
assembled supramolecular coordination complexes (SCCs)
with intriguing geometries and attractive properties, including
optical, sensing, and catalytic.[1–3] Despite the extraordinary
growth of the chemistry of SCCs, studies reporting on their
potential biomedical applications are so far extremely limited.
Recently, some research groups have started to exploit the
cavity-cored nature of 3D metallacages to develop innovative
drug delivery systems.[2,4–6] We and others focused our efforts
on the intrinsic anticancer potential of SCCs,[5] devoting
particular attention to those supramolecules where platinum
drives the self-assembly.[7–10] Pt-ensembles can in principle be
designed to mimic complex cellular regulatory motifs. There-
fore, they can act through unusual modes of action potentially
capable to overcome the drawbacks (for example resistance)
of clinically applied PtII drugs.[11] Nevertheless, apart from
preliminary reports on their cytotoxic activity, detailed
information about the in-cell fate of Pt-SCCs is still missing.
In this regard, Stang and Olenyuk reported on the
intracellular localization of two emissive PtII metallacycles.[12]
Their compounds were proposed to accumulate in lysosomes
of cancer cells producing low toxicity, yet effectively inducing
tumor shrinkage in mouse xenograft models.[12] Stang and his
team also developed theranostic nanoconstructs incorporat-
ing platinum metallacages that displayed in vivo anticancer
activity.[13, 14] A further demonstration of the potential of PtII-
SCCs in biomedicine was provided by Sleiman and Mao, who
discovered that PtII-based metallacycles display fairly good
ability to bind DNA G-quadruplexes (G4s) in solution.[15–18]
G4s are non-canonical DNA/RNA motifs enriched in impor-
tant regulatory regions,[19] and regarded as emerging targets
for anticancer drugs.[20] They recently achieved a “star” status
due to their subcellular visualization using G4-specific anti-
bodies.[21, 22] Furthermore, two G4 binders (CX-3543 and CX-
5461) have entered advanced clinical trials for human
cancers.[23,24]
In this context, we have recently reported on the promis-
ing DNA binding profiles of 4,4’-bipyridine-based dinuclear
PtII metallacyles.[25] Our SCCs, whilst not particularly cyto-
toxic (IC50 + 40 mm), distinctly influence the expression of
genes known to contain quadruplex motifs in their promoters,
with potency and selectivity which well correlate with the size
of the supramolecules.[25] Herein, we report on a new
hexagonal dinuclear PtII metallacycle (1, Figure 1) designed
to have DNA-binding capacity and favorable optical proper-
ties for tracking its in-cell fate when bound to different nucleic
acid structures.
Over the past few years we have developed a straightfor-
ward strategy for the self-assembly of dinuclear PtII-based
metallacycles.[26] Inspired by recent works of Wasielewski and
Stoddart on cyclophanes bearing isolated phenyl-extended
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viologen moieties,[27, 28] we argued that the ditopic pyridyl
ligand L1 (Figure 1a) would confer an adequate emission
profile to the final supramolecule and overcome quenching
effects typical of SCCs.[29–31] The highly emissive biphenyl-
extended viologen moiety (Figure 1, in turquoise) would
maintain a ligand-centered emission profile when incorpo-
rated in the corresponding dinuclear PtII-metallacycle 1 due
to the non-direct connectivity to the metal centers. Further-
more, the dimensions (ca. 200 c2) and the octacationic nature
of 1 are quite similar to those of our previously reported
DNA/quadruplex binders,[25] a fact that we envisaged would
translate as well into a comparable DNA-binding profile.
Synthesis of 1 was carried out according to methodologies
previously reported by us for similar SCCs (see Supporting
Information for details).[32]
Steady-state 3D excitation-emission spectra (Supporting
Information, Figure S1a,b) showed that 1 buffered solutions
emit in the blue with a maximum at 445 nm when excited at
360 nm (an absorption band ascribed to p–p* transitions of
the biphenyl moiety). The fluorescence profile of 1 is rather
similar to the one of its ligand L1, whose emission maximum is
slightly blue-shifted (lmax = 437 nm, Figure S1b in the Sup-
porting Information). This, together with the observation that
both 1 and L1 have emission lifetimes of about 2–3 ns
(Supporting Information, Figure S1c), suggest that fluores-
cence is mainly dependent on the excited states of the ligand,
as reported likewise for other PtII-SCCs.[12] Even though
ligand L1 is more emissive in water than 1 (fF = 0.84 at
437 nm, Figure S2 in the Supporting Information), the metal-
lacycle has a surprisingly good quantum yield in water (fF =
0.38 at 445 nm). This finding is in sharp contrast to what has
been recently observed for other platinum-based cages which
display high emission only in non-polar solvents.[33] Such an
aspect is particularly important for SCCs biological applica-
tions, making 1 a good candidate for tracking the cellular
distribution of this class of compounds.
After proving by NMR and UV/Vis spectroscopy that 1 is
stable overtime in water, buffered solutions, and cell culture
media (with or without fetal bovine serum) (Supporting
Information, Figure S3), we explored the interaction of the
metallacycle with different DNA sequences including duplex
DNA and G4 models. FRET, UV/Vis, fluorescence, and
circular dichroism assays showed that 1 is able to strongly
bind both duplex and quadruplex DNAs, with moderate
preference for parallel G4s (see Supporting Information and
Figure S4–S7 for a detailed discussion), similarly with what
was observed for other Pt-SCCs prepared by us previously.[25]
We then investigated the applicability of our newly
synthesized Pt-compound in biological settings, evaluating
its impact on the viability of non-transformed human
keratinocytes and human lung fibroblasts (HaCaT and
HLF) as well as of cancer cell models derived from different
primary origins including breast cancer, osteosarcoma, mel-
anoma, and glioblastoma (Figure 2a and Table S1 in the
Supporting Information). While HaCat cells were completely
resistant against the cytotoxic impact of the metallacycle, the
activity against highly proliferative HLF was comparable to
malignant cell types, where 1 showed IC50 values in the range
30–45 mm after 72 h of incubation, with MCF-7 and U2OS
being the most sensitive models. Ligand L1 was slightly less
active and followed the same trend (Supporting Information,
Figure S8a and Table S1). These results are in good agree-
ment with the general low cytotoxicity of similar Pt-SCCs
observed earlier by ourselves and Olenyuk.[12, 25] Combination
of 1 with cisplatin in MCF-7 cells (Supporting Information,
Figure S8b) gave rise to a slightly antagonistic effect suggest-
ing that they may share mutual targets (nucleic acids) but
exert a differing mode of action.
Figure 1. a) Synthesis of Pt-SCC 1. b) DFT optimized structure of 1.
Figure 2. a) Cell viability assessed by MTT assay following exposure to
1 (0–50 mm). b) Normalized emission signatures of 1 in MCF-7 cells
acquired with confocal microscope (blue filled area) and in cell-free
buffer acquired with a spectrofluorometer. c) Flow cytometric analysis
of U2OS cells treated with 50 mm of L1 (grey) and 1 (blue) over time
(lexc = 405 nm, lem = 450/50 nm), p<0.001, 1-way ANOVA, Bonferroni
post-test. d) Airyscan super-resolution microscopy images of U2OS
cells treated with 5 mm 1 at short- (10 ms) and long-term (100 ms)
exposure (lexc =405 nm, lem =450/30 nm) indicating selective photo-
bleaching effects of 1. e) CLSM and DIC microscopy images acquired
for PFA-fixed MCF-7 cells incubated for 30 min with 1 at 50 mm
(lexc = 405 nm). Scale bars =10 mm.
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MCF-7 and U2OS cell sensitivity to 1 was also tested
through clonogenic assay, selecting a longer incubation time
(7 days). Both cell lines showed impaired colony formation
upon incubation with 1 at already 15–20 mm (Supporting
Information, Figure S9). Interestingly, the long-term treat-
ment had a stronger impact on U2OS compared to MCF-7
cells (15 mm vs. 20 mm, respectively). Conversely, cell cycle
distribution analysis revealed that after 24 h incubation there
was a significant dose-dependent cell accumulation in G0/G1
phase and clear-cut cell death induction only in MCF-7 cells,
while U2OS cell populations presented no appreciable
changes at this comparably short incubation time (Supporting
Information, Figure S10).
To elucidate whether 1 indeed targets G4 regulated genes,
whole genome gene expression analyses were performed on
U2OS cells comparing the impact of the metallacycle with
that of pyridostatin (PDS), a well-known G4 stabilizer.[21]
Gene set enrichment analysis (GSEA) clearly revealed that
1 preferentially targets genes located in chromosomal regions
enriched in G4 structures[34] with multiple KEGG terms
similarly suppressed or activated by 1 and PDS (Supporting
Information, Figure S11a–c).
Confocal laser scanning microscopy (CLSM) was used to
evaluate 1 subcellular emission fingerprint. MCF-7 cells
treated with 1 revealed an intense blue fluorescence signal
in the range 420–518 nm (lexc = 405 nm, Figure 2b and S12 in
the Supporting Information), showing a nearly perfect over-
lap with the emission band obtained in cell-free conditions
(Figure 2b). Flow cytometry analysis of 1-treated U2OS cells
nicely confirmed CLSM results. Pt-SCC 1 gave rise to
a considerable emission in the blue portion of the spectrum
(lexc = 405 nm) (Supporting Information, Figure S13a). Inter-
estingly, 1-associated emission decreased when cells were
treated concomitantly with PDS suggesting G4s involve-
ment.[21] In contrast it was unaffected by combination with
cisplatin indicating a different binding mechanism (Support-
ing Information, Figure S13b). In CLSM analyses as well as in
FACS experiments, L1 emission was considerably lower.
FACS, for example, displayed a drastic reduction of the blue
fluorescence of 94% for L1 at lexc = 405 nm (Supporting
Information, Figure S13). The efficiency of 1 emission in cell
can be attributed to the increased rigidity imposed by the
metallacycle to the biphenyl-extended fluorophore.[28] FACS
analysis of U2OS cells treated with 1 showed a significant
drug accumulation within the first hour of incubation, while
L1 did not share the same accumulation features (Figure 2c).
Live cell imaging indicated that exposure of U2OS cells to
compound 1 at 35 mm produced an increase in fluorescence
overtime (Supporting Information, Figure S14) which nicely
corroborates FACS results. The emission of the ligand was in
this case below the detection limit of the instrument
(Supporting Information, Figure S15). Crucially, the different
emissive behavior of L1 compared to 1, observed using
diverse experiments and techniques, suggests a different
trafficking dynamic inside the cells for the two compounds
and allows ruling out possible cellular decomposition of the
platinum ensemble to its free building blocks.
Drug distribution within cells was further studied by
CLSM. Super-resolution airy-scan images of U2OS cells fixed
with MeOH and incubated with 1 showed a structured blue
staining of the whole nucleus confirming binding of 1 to DNA.
Extended UV exposure, however, produced a photobleaching
effect which was dependent on the sub-nuclear region. Hence,
at G4-rich loci, 1 photobleaching was distinctly less efficient
resulting in the labelling of nucleoli-like substructures (Fig-
ure 2d). This effect was corroborated by time-lapse fluores-
cence microscopy (Supporting Information, Figure S16).
Confocal micrographs of U2OS and MCF-7 cells fixed with
paraformaldehyde (PFA) confirmed the pan-nuclear blue
fluorescent staining induced by 1 (Figure 2e and S17a in the
Supporting Information). Interestingly, images of fixed cells
exposed to 1, acquired using DIC (differential interference
contrast) mode, revealed a strong contrast enhancement of
nuclei and a clear-cut “dark” staining of the nucleoli-like
substructures (see below). This unique effect is independent
of the fixation method since MCF-7 cells fixed with methanol
gave the same outcome (Supporting Information, Fig-
ure S17b). Such a contrast enrichment effect was not detected
when cells were incubated with L1 or DAPI, a conventional
nuclear DNA stain (Supporting Information Figure S17a).
To have a first hint about possible interaction of 1 with
G4s in cells, fluorescence competition assays were performed
and analyzed by live cell imaging microscopy. The G4-binders
TMPyP4 and Thioflavin-T (ThT) were used since they are
also intracellularly fluorescent. In detail, TMPyP4 is a non-
selective porphyrin-based binder displaying a red emission,[35]
while ThT is known for its green fluorescent, G4-selective,
light-up effect both in solution[36] and in cells.[37] MCF-7 cells
incubated with the porphyrin and 1 showed an initial
TMPyP4-associated red fluorescence localized in the nuclei
that turned blue overtime (Supporting Information, Fig-
ure S18a and Video S1). The same effect was obtained with
ThT/1 incubation, with the ThT-associated nucleolar green
emission being replaced by the blue signals induced by
1 (Supporting Information, Figure S18b and Video S2). This
outcome clearly indicated that 1 acts as competitor of both
TMPyP4 and ThT for the same binding sites (duplex and
G4s), showing an enhanced long-term target affinity. It is
worth noting that live cell imaging was affected by consid-
erable cell death after treatment with 1, probably based on
phototoxicity or synergistic effects when combined with
TMPyP4 and ThT. We verified the latter hypothesis through
viability assays, demonstrating that co-incubations of 1 with
ThT (or PDS) produced strong synergistic cytotoxicity in
MCF-7 and U2OS cells (Supporting Information, Fig-
ure S18c).
A competition assay was also performed in cells fixed
after ThT exposure. Metallacycle 1 blocked the G4-selective
green fluorescence staining of nucleoli by ThT (Figure 3a and
S19a in the Supporting Information), comparable to recent
reports for PDS.[37] Similarly, 1 completely displaced the green
nucleoli marker SYTOURNASelect (SYTO, Figure 3b),
while it did not interact with mitochondrial labelling by
MitoTracker Red (MR, Figure S19b in the Supporting
Information).
To further evaluate that cellular distribution of 1 could be
governed also by the presence of G4s besides duplex DNA,
a series of immunofluorescence studies using the quadruplex
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specific antibody BG4[21,22] was performed (Figure 3 c–e).
Fluorescence microscopy images of MeOH-fixed MCF-7 cells
were acquired after BG4 immunofluorescence and subse-
quent 1 staining at extended UV exposure(photobleaching).
Figure 3c depicts the clear and distinct cellular co-localization
of BG4-associated red G4-rich foci with photobleaching-
resistant 1 fluorescence, both enriched in nucleolar regions.
We then repeated BG4 co-localization experiments,
taking advantage of the clear-cut “dark” staining of sub-
nuclear structure observed previously for compound 1. CLSM
images of MeOH fixed MCF-7 cells (Figure 3 d) proves that,
also in this case, 1 co-localized with the anti-G4 immunos-
taining by BG4. In detail, our Pt-SCC labelled the whole
nucleus with a blue fluorescence and rendered nuclear
substructures visible in the DIC channel as dark stains. BG4
revealed red signals exactly in the same regions (lexc =
555 nm) as depicted from representative pixel intensity plots
of fluorescence and DIC images (Supporting Information,
Figure S20). It should be noted that BG4 epitope distribution
is known to be dependent on the fixation method used.
Recent studies reported that the antibody labels preferen-
tially nucleoli when MeOH is used for fixation.[38] Hence, our
experiments indicate that Pt-metallacycle 1 actually targets
G4-rich nucleolar structures. The co-labelling assays were
repeated both changing either the incubation order or the
fixation method. When MCF-7 cells were fixed with MeOH,
incubated with 1 and then with the antibody, a loss of BG4
staining in the nucleoli was produced (Supporting Informa-
tion, Figure S21a). The micrographs showed instead a weak
overall red labelling within the cytoplasm. The outcome was
similar when living cells were pre-treated with 1, then fixed
and finally labelled with BG4 (Supporting Information,
Figure S21b). Additionally, comparable displacement effects
were obtained when MCF-7 cells were fixed with PFA.
Incubation with BG4 produced the classic nuclear red
punctate staining pattern (Figure 3e and Figure S22 in the
Supporting Information) as reported by Biffi et al.[21,22] When
PFA-fixed cells were pre-treated with 1, the BG4 punctate
pattern got diffused, appearing enriched in the cytoplasm,
demonstrating that metallacycle 1 disrupted BG4 ability to
stain G4s in the nuclear region. Eventually, co-incubation of
1 and BG4 rendered comparable results at the level of
individual chromosomes, obtaining the same effect (Support-
ing Information, Figure S23d).
Overall, these experiments clearly indicate that 1, once
inside the nucleus (and the nucleoli), interacts with nucleic
acids and interferes with the G4 epitope recognition by BG4.
Besides its cellular co-localization with BG4 and its
emissive properties, our Pt-metallacycle showed the unique
ability to provide well-contrasted images of cells in trans-
mission (monochrome) DIC mode. The brightfield channel is
often ignored in drug accumulation studies for several reasons
(poor contrast, difficult localization of cell borders, faint
nuclei and others).[39] Nevertheless, we were particularly
intrigued by the clear-cut and intense dark staining of nucleoli
provided by 1, which resulted to be easily reproducible and
independent of the fixation method and cell line used.
Considering the complex optical mechanism at the basis
of DIC microscopy,[40] we hypothesized that the dark nucle-
olar “staining” could arise from absorption or refraction (or
both) of the light by the Pt-metallacycle within the sub-
nuclear structures, associated to a simultaneous quenching
(and photobleaching resistance) of its blue fluorescence. The
UV/Vis spectrum of 1 in solution showed a band centred at
355 nm with a tail ending at around 430 nm (Figure 4a).
Interestingly, the absorbance at 355 nm was significantly red-
shifted when aliquots of pre-folded parallel quadruplex were
added, resulting in a considerable increase in absorption at
405 nm (Figure 4 a). This effect was noticeably less pro-
nounced when the same experiment was performed using
a double-stranded DNA model (Supporting Information,
Figure S5b). At the same time, a strong fluorescence quench-
ing was observed after interaction of 1 with the same parallel
G4 in solution (Figure 4b). Crucially, the quenching was less
pronounced after the interaction with ds-DNA, as confirmed
by the binding and the Stern–Volmer constants lower in two
Figure 3. a) Fluorescence microscopy images of MeOH fixed MCF-7
cells, stained with ThT (5 mm) with and without 1 (5 mm) as indicated.
Metallacycle 1 prevented ThT G4-specfic nucleolar signals. b) Fluores-
cence microscopy images of U2OS cells stained with SYTO (500 nm),
then fixed with MeOH and exposed to 1 (5 mm). c) Fluorescence
microscopy images of MeOH-fixed MCF-7 cells co-stained with BG4
and 1 (order: BG4, 1) after photobleaching. d,e) CLSM images of
MeOH-fixed MCF-7 cells co-stained with BG4 and 1 (order: BG4, 1)
e) PFA-fixed MCF-7 cells co-stained with 1 and BG4 (order: 1, BG4).
Scale bars = 10 mm.
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and one orders of magnitudes, respectively (Supporting
Information, Figure S6).
Furthermore, MCF-7 cells fixed with MeOH and incu-
bated with 1 afforded cell images with dramatically enhanced
contrast in the DIC setting with 405 nm excitation (where the
metallacycle-G4 adduct preferentially absorbs light, Fig-
ure 4a), depicting prominently visible nucleoli (Figure 4 c,d).
When changing the excitation wavelength to 488 nm, just
faint cell contours typical for DIC remained visible (Fig-
ure 4e). Of note, nucleoli staining was not observed when
fixed MCF-7 cells were incubated with another Pt-SCC,
selected among our toolbox of metallacycles because of its
transparency at 405 nm (Supporting Information, Fig-
ure S24). Likewise, staining of fixed MCF-7 cells with DAPI
resulted in the expected blue chromatin staining without any
contrast enhancement in the DIC setting. While nucleoli
remained invisible in absorption imaging, they appeared
darker in the blue fluorescence channel based on the well-
known binding of DAPI to AT-rich regions (Supporting
Information, Figure S25).
These considerations strongly suggest that the dark
staining is produced by absorption of 1 interacting with G4
structures within the nucleoli in association with initial
distinct fluorescence quenching.
In summary, we thoroughly described the intracellular
fate of a Pt-SCC. Based on its fluorescence properties, we
show, for the first time for a Pt-based SCC, that 1 is taken up
by cancer cells and accumulates in the nucleus. Furthermore,
the particular alterations of the metallacycle optical features
when interacting with G4 as compared to duplex DNA
offered a unique tool for its subcel-
lular interaction profiling. Com-
pound 1 preferentially targets nucle-
olar structures, co-localizes with
a G4-specific antibody and displaces
well-known G4 stabilizers. Our in-
solution and cellular results, together
with the information that nucleoli are
particularly rich in G4 forming
sequences,[38, 41–43] strongly support
that these noncanonical nucleic acid
structures are also the final target of
the Pt-SCC. Quarfloxin (CX-3543),
the first-in-class G4-binder in clinical
trials, is believed to exert its anti-
cancer activity through a similar
mechanism, that is, precisely by accu-
mulation in nucleoli.[23] To conclude,
platinum-based SCCs are an
extremely versatile class of com-
pounds with the potential to mimic
recognition properties of complex
biological systems. This manuscript
provides evidence that nucleic acids,
and in particular G-quadruplex struc-
tures, can be key cellular targets of
platinum-driven supramolecular
coordination compounds. Our find-
ings open new avenues in the devel-
opment of anticancer platinum-based SCCs with promising
and defined mechanisms of action.
Acknowledgements
A.T. has received funding from the Mahlke–Obermann
Stiftung and the European UnionQs Seventh Framework
Programme (grant agreement no. 609431). C.D. is a recipient
of a DOC Fellowship of the Austrian Academy of Sciences
(24660). C.P. is grateful to the Ministerio de Econom&a,
Industria y Competitividad and FEDER (CTQ2016-75629-P).
A.T. is grateful to Prof. L. Salassa for his support and advice.
Conflict of interest
The authors declare no conflict of interest.
Keywords: G-quadruplex · metallacycle · platinum · SCC ·
subcellular localization
How to cite: Angew. Chem. Int. Ed. 2019, 58, 8007–8012
Angew. Chem. 2019, 131, 8091–8096
[1] R. Chakrabarty, P. S. Mukherjee, P. J. Stang, Chem. Rev. 2011,
111, 6810 – 6918.
[2] T. R. Cook, P. J. Stang, Chem. Rev. 2015, 115, 7001 – 7045.
[3] A. J. McConnell, C. S. Wood, P. P. Neelakandan, J. R. Nitschke,
Chem. Rev. 2015, 115, 7729 – 7793.
Figure 4. a) UV/Vis absorption spectrum of 1 alone (up) and in combination with increasing
amount of c-Kit2 G4 solution (down). b) Fluorescence titration of 1 with c-Kit2 G4. c) Image of
MCF-7 cells fixed with MeOH and incubated with 1 acquired using DIC mode at 405 nm.
d) Differences in absorption within subnuclear regions of a representative 1-treated nucleus derived
from c) visualized by three-dimensional surface plotting of single pixel intensities of the inverted
DIC image. e) Image of MCF-7 cells fixed with MeOH and incubated with 1 acquired using DIC
mode at 488 nm. Scale bars = 10 mm.
Angewandte
ChemieCommunications
8011Angew. Chem. Int. Ed. 2019, 58, 8007 –8012 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.angewandte.org
[4] A. Casini, B. Woods, M. Wenzel, Inorg. Chem. 2017, 56, 14715 –
14729.
[5] T. R. Cook, V. Vajpayee, M. H. Lee, P. J. Stang, K. W. Chi, Acc.
Chem. Res. 2013, 46, 2464 – 2474.
[6] B. Therrien, G. Sgss-Fink, P. Govindaswamy, A. K. Renfrew, P. J.
Dyson, Angew. Chem. Int. Ed. 2008, 47, 3773 – 3776; Angew.
Chem. 2008, 120, 3833 – 3836.
[7] A. Ahmedova, D. Momekova, M. Yamashina, P. Shestakova, G.
Momekov, M. Akita, M. Yoshizawa, Chem. Asian J. 2016, 11,
474 – 477.
[8] F. Kaiser, A. Schmidt, W. Heydenreuter, P. J. Altmann, A.
Casini, S. A. Sieber, F. E. Kghn, Eur. J. Inorg. Chem. 2016, 5181 –
5181.
[9] A. Terenzi, C. Ducani, V. Blanco, L. Zerzankova, A. F. West-
endorf, C. Peinador, J. M. Quintela, P. J. Bednarski, G. Barone,
M. J. Hannon, Chem. Eur. J. 2012, 18, 10983 – 10990.
[10] M. Mounir, J. Lorenzo, M. Ferrer, M. J. Prieto, O. Rossell, F. X.
AvilHs, V. Moreno, J. Inorg. Biochem. 2007, 101, 660 – 666.
[11] B. Englinger, C. Pirker, P. Heffeter, A. Terenzi, C. R. Kowol,
B. K. Keppler, W. Berger, Chem. Rev. 2019, 119, 1519 – 1624.
[12] I. V. Grishagin, J. B. Pollock, S. Kushal, T. R. Cook, P. J. Stang,
B. Z. Olenyuk, Proc. Natl. Acad. Sci. USA 2014, 111, 18448 –
18453.
[13] G. Yu, T. R. Cook, Y. Li, X. Yan, D. Wu, L. Shao, J. Shen, G.
Tang, F. Huang, X. Chen, et al., Proc. Natl. Acad. Sci. 2016, 113,
13720 – 13725.
[14] G. Yu, M. Zhang, M. L. Saha, Z. Mao, J. Chen, Y. Yao, Z. Zhou,
Y. Liu, C. Gao, F. Huang, et al., J. Am. Chem. Soc. 2017, 139,
15940 – 15949.
[15] R. Kieltyka, P. Englebienne, J. Fakhoury, C. Autexier, N.
Moitessier, H. F. Sleiman, J. Am. Chem. Soc. 2008, 130, 10040 –
10041.
[16] X.-H. Zheng, H.-Y. Chen, M.-L. Tong, L.-N. Ji, Z.-W. Mao,
Chem. Commun. 2012, 48, 7607 – 7609.
[17] X.-H. Zheng, Y.-F. Zhong, C.-P. Tan, L.-N. Ji, Z.-W. Mao, Dalton
Trans. 2012, 41, 11807 – 11812.
[18] A. Garci, K. J. Castor, J. Fakhoury, J. L. Do, J. Di Trani, P.
Chidchob, R. S. Stein, A. K. Mittermaier, T. Friščić, H. Sleiman,
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